Invention Grant
- Patent Title: Pyrrolotriazine kinase inhibitors
- Patent Title (中): 吡咯并三嗪激酶抑制剂
-
Application No.: US12411724Application Date: 2009-03-26
-
Publication No.: US07879855B2Publication Date: 2011-02-01
- Inventor: Mark D. Wittman , Harold Mastalerz , Kurt Zimmermann , Mark G. Saulnier , Upender Velaparthi , Dolatrai M. Vyas , Guifen Zhang , Walter Lewis Johnson , David B. Frennesson , Xiaopeng Sang , Peiying Liu , David R. Langley
- Applicant: Mark D. Wittman , Harold Mastalerz , Kurt Zimmermann , Mark G. Saulnier , Upender Velaparthi , Dolatrai M. Vyas , Guifen Zhang , Walter Lewis Johnson , David B. Frennesson , Xiaopeng Sang , Peiying Liu , David R. Langley
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Elliott Korsen
- Main IPC: A61K31/53
- IPC: A61K31/53 ; A61P35/00 ; C07D487/04 ; C07D401/14 ; A61P19/02
Abstract:
The invention provides compounds of formula I and pharmaceutically acceptable salts thereof. The formula I compounds inhibit tyrosine kinase activity thereby making them useful as anticancer agents and for the treatment of Alzheimer's Disease.
Public/Granted literature
- US20090239838A1 PYRROLOTRIAZINE KINASE INHIBITORS Public/Granted day:2009-09-24
Information query
